← Back to patent-cliff list
Bofutrelvir
Tier C — Watch / tradeBofutrelvir
Frontier Biotechnologies Inc.
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：3CLp
Indications (approved)：COVID-19
Regional status
US
Phase I
2021-03-17
EU
-
China
Phase III
2022-09-14
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Bofutrelvir?
Approved indications include: COVID-19.
When does the Bofutrelvir patent expire?
No public expiry year is available for Bofutrelvir yet; this page updates once verified.
How do I get a quote for Bofutrelvir intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-05